ClinicalTrials.gg
CompletedNCT02514564Updated Mar 27, 2026

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

An observational study in Cardiovascular Diseases, sponsored by Instituto Nacional de Cardiologia de Laranjeiras. Completed at 1 site in Brazil. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Instituto Nacional de Cardiologia de Laranjeiras · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
115
Ages
40 Years to 80 Years
Sex
All
01

Study summary

This study evaluates the effects of different volumes of aerobic exercise training in cardiovascular parameters of patients with cardiovascular diseases enrolled in a cardiac rehabilitation program.

Read the detailed description

Aerobic exercise training is well known to improve endothelium dependent vasodilatation in the microcirculation. However, the impact of exercise frequency on this response in patients with coronary artery disease remains unclear.

02

Conditions studied

  • Cardiovascular Diseases
03

In context

Cardiovascular Diseases

5,374 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.

This study's enrollment of 115 is below the median of 534 across 1,577 observational studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Instituto Nacional de Cardiologia de Laranjeiras is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients treated in the hospital in which the exercise will be performed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • sedentarism for at least 6 months;
  • clinical diagnosis for coronary artery disease (occurrence of any acute coronary syndrome, including ST elevation or non-ST elevation myocardial infarction or unstable angina or by the diagnosis of obstructive coronary artery disease on coronary angiography in patients with stable angina).

Exclusion criteria

Exclusion Criteria:

  • nephropathies;
  • decompensated cardiovascular diseases;
  • liver diseases.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
115 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • 2x/wk

    This group will be consisted of patients that will perform exercise two times a week.

    Behavioral: Exercise

  • 3x/wk

    This group will be consisted of patients that will perform exercise three times a week.

    Behavioral: Exercise

  • Control

    This group will not perform exercise.

    Behavioral: Sedentarism

Interventions

  • BehavioralExercise

    Patients included in the study will be enrolled in a cardiac rehabilitation program, in an independent manner of the study protocols.

  • BehavioralSedentarism

    Participants will remain sedentary.

06

What researchers measure

Primary outcomes

  1. Changes in Skin microvascular blood flow

    Measured through a Laser Speckle Contrast Imaging equipment

    Time frame: Change from baseline in skin microvascular blood flow at 6 months

Secondary outcomes

  1. Change in peak oxygen consumption

    Measured at a maximal graded exercise test

    Time frame: Change from baseline in peak oxygen consumption at 6 months

  2. Change in weight

    Measured with a calibrated digital scale

    Time frame: Change from baseline in weight at 6 months

07

Study locations

1 site
  • Instituto Nacional de Cardiologia
    Rio de Janeiro, Rio de Janeiro 21040-900, Brazil
08

References and documents

Publications

  • Souza EG, De Lorenzo A, Huguenin G, Oliveira GM, Tibirica E. Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging. Coron Artery Dis. 2014 Jan;25(1):23-8. doi: 10.1097/MCA.0000000000000055. PubMed 24172594 ↗
  • Cordovil I, Huguenin G, Rosa G, Bello A, Kohler O, de Moraes R, Tibirica E. Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging. Microvasc Res. 2012 May;83(3):376-9. doi: 10.1016/j.mvr.2012.01.004. Epub 2012 Jan 31. PubMed 22326551 ↗
  • Borges JP, Mediano MF, Farinatti P, Coelho MP, Nascimento PM, Lopes GO, Kopiler DA, Tibirica E. The Effects of Unsupervised Home-based Exercise Upon Functional Capacity After 6 Months of Discharge From Cardiac Rehabilitation: A Retrospective Observational Study. J Phys Act Health. 2016 Nov;13(11):1230-1235. doi: 10.1123/jpah.2016-0058. Epub 2016 Aug 24. PubMed 27333938 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2014, a primary completion of Dec 2016 and a completion of Dec 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2015
First posted
Aug 3, 2015
Start
Dec 2014
Primary completionActual
Dec 2016
CompletionActual
Dec 2016
Last update
Mar 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02514564
Lead sponsor
Instituto Nacional de Cardiologia de Laranjeiras
Responsible party
Juliana Pereira Borges (PhD, Instituto Nacional de Cardiologia de Laranjeiras) — Principal investigator
First posted
Aug 3, 2015
Start date
Dec 2014
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Mar 27, 2026

Study contacts

Eduardo V Tibiriçá, PhD
study director · Instituto Fernandes Figueira

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion